Abstract
Background
Iliac crest has long been the gold standard for lumbar fusion, but concerns over donor site morbidity have led to a wide variety of bone graft substitutes. Despite prolific research, a general consensus is yet to be reached on bone graft materials that lead to optimal fusion.
Purpose
The purpose of this review is to evaluate the current literature for bone graft material options that maximize fusion rate in posterolateral lumbar fusion surgery.
Design
Systematic Review.
Methods
A PRISMA—compliant systematic review of PubMed, EMBASE, and the Web of Science was conducted. Included studies were published from January 2000 to July 2015, were clinical human research studies involving available autograft, allograft, or synthetic bone graft options in posterolateral lumbar spine fusion, and reported radiographic fusion rate as a primary end outcome. This research had no funding source and the authors have no conflicts to declare.
Results
81 articles underwent full-text review, and 48 were included in this study. 18 studies assessed fusion rate by plain radiographs alone (37.5%), while 6 used CT scan (12.5%), and 24 used both (50.0%). 45 studies looked at ICBG in conjunction with LAG (29), BCP(1), APC (2), BMPs (6), or DBM (1). Aggregate mean fusion rates among these ranged from 68.0 to 91.5%. 22 studies evaluated fusion rates of LAG, either isolated (3) or combined with ceramic extenders (8), DBM (4), BMP (1), BMA (4), APC (1), or ICBG(1). Aggregate mean fusion rate ranged from 75 to 95.5%. With the exception of studies involving allograft (mean fusion rate 40.0%), the mean fusion rate for all other graft combinations exceeded 70.0%.
Conclusions
While our results find that LAG+BMA provided highest fusion rate, most material options analyzed in this study provide comparable fusion outcomes. The ideal graft option must incorporate a combination of materials with osteoconductive, osteoinductive, and osteogenic properties. Our results represent the robust and dynamic nature of the current state of lumbar graft technology.
Graphical abstract
These slides can be retrieved under Electronic Supplementary Material.
Similar content being viewed by others
Change history
07 July 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00586-021-06900-6
References
Carreon LY, Glassman SD, Djurasovic M et al (2009) RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility study. Spine 34(3):238–243. https://doi.org/10.1097/BRS.0b013e31818ffabe
Korovessis P, Koureas G, Zacharatos S, Papazisis Z, Lambiris E (2005) Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft versus coralline hydroxyapatite. Eur Spine J 14(7):630–638. https://doi.org/10.1007/s00586-004-0855-5
Lee K-B, Taghavi CE, Hsu MS et al (2010) The efficacy of rhBMP-2 versus autograft for posterolateral lumbar spine fusion in elderly patients. Eur Spine J 19(6):924–930. https://doi.org/10.1007/s00586-009-1248-6
Vaccaro AR, Stubbs HA, Block JE (2007) Demineralized bone matrix composite grafting for posterolateral spinal fusion. Orthopedics 30(7):567–570
Sassard WR, Eidman DK, Gray PM et al (2000) Augmenting local bone with Grafton demineralized bone matrix for posterolateral lumbar spine fusion: avoiding second site autologous bone harvest. Orthopedics 23(10):1059–1064 (discussion 1064–1065)
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https://doi.org/10.1136/bmj.b2700
Wright JG, Swiontkowski MF, Heckman JD (2003) Introducing levels of evidence to the journal. J Bone Joint Surg Am 85(1):1–3
Dimar JR, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY (2009) Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graft. Spine J 9(11):880–885. https://doi.org/10.1016/j.spinee.2009.03.013
Dai L-Y, Jiang L-S (2008) Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up. Spine 33(12):1299–1304. https://doi.org/10.1097/BRS.0b013e3181732a8e
Fischgrund JS, Mackay M, Herkowitz HN, Brower R, Montgomery DM, Kurz LT (1997) 1997 Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine 22(24):2807–2812
Kimura I, Shingu H, Murata M, Hashiguchi H (2001) Lumbar posterolateral fusion alone or with transpedicular instrumentation in L4–L5 degenerative spondylolisthesis. J Spin Disord 14(4):301–310
Dimar JR, Glassman SD, Burkus KJ, Carreon LY (2006) Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 31(22):2534–2539. https://doi.org/10.1097/01.brs.0000240715.78657.81 (discussion 2540)
Epstein NE (2006) A preliminary study of the efficacy of Beta Tricalcium Phosphate as a bone expander for instrumented posterolateral lumbar fusions. J Spinal Disord Tech 19(6):424–429
Vaccaro AR, Whang PG, Patel T et al (2008) The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 8(3):457–465. https://doi.org/10.1016/j.spinee.2007.03.012
Jorgenson SS, Lowe TG, France J, Sabin J (1994) A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients. Spine 19(18):2048–2053
Sengupta DK, Truumees E, Patel CK et al (2006) Outcome of local bone versus autogenous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine. Spine 31(9):985–991. https://doi.org/10.1097/01.brs.0000215048.51237.3c
Acebal-Cortina G, Suárez-Suárez MA, García-Menéndez C, Moro-Barrero L, Iglesias-Colao R, Torres-Pérez A (2011) Evaluation of autologous platelet concentrate for intertransverse lumbar fusion. Eur Spine J 20(Suppl 3):361–366. https://doi.org/10.1007/s00586-011-1904-5
Alexander DI, Manson NA, Mitchell MJ (2001) Efficacy of calcium sulfate plus decompression bone in lumbar and lumbosacral spinal fusion: preliminary results in 40 patients. Can J Surg 44(4):262–266
Chen W-J, Tsai T-T, Chen L-H et al (2005) The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion. Spine 30(20):2293–2297
Kanayama M, Hashimoto T, Shigenobu K, Yamane S, Bauer TW, Togawa D (2006) A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine 31(10):1067–1074. https://doi.org/10.1097/01.brs.0000216444.01888.21
Odri GA, Hami A, Pomero V et al (2012) Development of a per-operative procedure for concentrated bone marrow adjunction in postero–lateral lumbar fusion: radiological, biological and clinical assessment. Eur Spine J 21(12):2665–2672. https://doi.org/10.1007/s00586-012-2375-z
Hart R, Komzák M, Okál F, Náhlík D, Jajtner P, Puskeiler M (2014) Allograft alone versus allograft with bone marrow concentrate for the healing of the instrumented posterolateral lumbar fusion. Spine J 14(7):1318–1324. https://doi.org/10.1016/j.spinee.2013.12.014
Acharya NK, Kumar RJ, Varma HK, Menon VK (2008) Hydroxyapatite-bioactive glass ceramic composite as stand-alone graft substitute for posterolateral fusion of lumbar spine: a prospective matched, and controlled study. J Spin Disord Tech 21(2):106–111. https://doi.org/10.1097/BSD.0b013e31805fea1f
Jenis LG, Banco RJ (2010) Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion. Spine 35(20):E1058–E1063. https://doi.org/10.1097/BRS.0b013e3181df196f
Moro-Barrero L, Acebal-Cortina G, Suárez-Suárez M, Pérez-Redondo J, Murcia-Mazón A, López-Muñiz A (2007) Radiographic analysis of fusion mass using fresh autologous bone marrow with ceramic composites as an alternative to autologous bone graft. J Spin Disord Tech 20(6):409–415
Ploumis A, Albert TJ, Brown Z, Mehbod AA, Transfeldt EE (2010) Healos graft carrier with bone marrow aspirate instead of allograft as adjunct to local autograft for posterolateral fusion in degenerative lumbar scoliosis: a minimum 2-year follow-up study. J Neurosurg Spine 13(2):211–215. https://doi.org/10.3171/2010.3.SPINE09603
Carreon LY, Glassman SD, Anekstein Y, Puno RM (2005) Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine 30(9):E243–E246 (discussion E247)
Boden SD, Kang J, Sandhu H, Heller JG (2002) Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27(23):2662–2673. https://doi.org/10.1097/01.BRS.0000035320.82533.06
Kang J, An H, Hilibrand A, Yoon ST, Kavanagh E, Boden S (2012) Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions. Spine 37(12):1083–1091. https://doi.org/10.1097/BRS.0b013e31823ed817
Vaccaro AR, Patel T, Fischgrund J et al (2004) A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 29(17):1885–1892
Singh K, Smucker JD, Gill S, Boden SD (2006) Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spin Disord Tech 19(6):416–423
Epstein NE (2008) An analysis of non-instrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate. Spine J 8(6):882–887. https://doi.org/10.1016/j.spinee.2007.11.005
Park DK, Kim SS, Thakur N, Boden SD (2013) Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis. Spine 38(12):E738–E747. https://doi.org/10.1097/BRS.0b013e31828fd23c
Coetzee AS (1988) Regeneration of bone in the presence of calcium sulfate. Arch Otolaryngol 106(7):405–409
Hadjipavlou AG, Simmons JW, Yang J, Nicodemus CL, Esch O, Simmons DJ (2000) Plaster of Paris as an osteoconductive material for interbody vertebral fusion in mature sheep. Spine 25(1):10–15 (discussion 16)
Turner TM, Urban RM, Gitelis S, Haggard WO, Richelsoph K (2003) Resorption evaluation of a large bolus of calcium sulfate in a canine medullary defect. Orthopedics 26(5 Suppl):s577–s579
Sidqui M, Collin P, Vitte C, Forest N (1995) Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials 16(17):1327–1332
Blom AW, Cunningham JL, Hughes G et al (2005) The compatibility of ceramic bone graft substitutes as allograft extenders for use in impaction grafting of the femur. J Bone Joint Surg Br 87(3):421–425
Hurlbert RJ, Alexander D, Bailey S et al (2013) rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial. Spine 38(25):2139–2148. https://doi.org/10.1097/BRS.0000000000000007
Johnsson R, Strömqvist B, Aspenberg P (2002) Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human non-instrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies. Spine 27(23):2654–2661. https://doi.org/10.1097/01.BRS.0000035339.83704.60
Gupta A, Kukkar N, Sharif K, Main BJ, Albers CE, El-Amin SF III (2015) Bone graft substitutes for spine fusion: a brief review. World J Orthop 6(6):449–456. https://doi.org/10.5312/wjo.v6.i6.449
Epstein NE (2009) Beta tricalcium phosphate: observation of use in 100 posterolateral lumbar instrumented fusions. Spine J 9(8):630–638. https://doi.org/10.1016/j.spinee.2009.04.007
Glassman SD, Dimar JR, Carreon LY, Campbell MJ, Puno RM, Johnson JR (2005) Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine 30(15):1694–1698
Glassman SD, Dimar JR, Burkus K et al (2007) The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers. Spine 32(15):1693–1698. https://doi.org/10.1097/BRS.0b013e318074c366
Bae HW, Stambough J, Glassman SD, Burkus JK (2007) 18. Level-1 data comparing rhBMP-2/ACS combined with an osteoconductive bulking agent with iliac crest bone graft in posterolateral lumbar fusion. Spine J 7(5):9S. https://doi.org/10.1016/j.spinee.2007.07.024
Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD (2009) Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am 91(7):1604–1613. https://doi.org/10.2106/JBJS.G.01157
Burkus JK, Dorchak JD, Sanders DL (2003) Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine 28(4):372–377. https://doi.org/10.1097/01.BRS.0000048469.45035.B9
Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA (2002) Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 27(21):2396–2408. https://doi.org/10.1097/01.BRS.0000030193.26290.DD
Slosar PJ, Josey R, Reynolds J (2007) Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J 7(3):301–307. https://doi.org/10.1016/j.spinee.2006.10.015
Kasai Y, Takegami K, Uchida A (2003) Mixture ratios of local bone to artificial bone in lumbar posterolateral fusion. J Spinal Disord Tech 16(1):31–37
Frantzén J, Rantakokko J, Aro HT et al (2011) Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up. J Spinal Disord Tech 24(7):455–461. https://doi.org/10.1097/BSD.0b013e31822a20c6
Vaccaro AR, Anderson DG, Patel T et al (2005) Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine 30(24):2709–2716
Buser Z, Brodke DS, Youssef JA, Meisel HJ, Myhre SL, Hashimoto R, Park JB, Tim Yoon S, Wang JC (2016) Synthetic bone graft versus autograft or allograft for spinal fusion: a systematic review. J Neurosurg Spine 25(4):509–516
Tuchman A, Brodke DS, Youssef JA, Meisel HJ, Dettori JR, Park JB, Yoon ST, Wang JC (2016) Iliac crest bone graft versus local autograft or allograft for lumbar spinal fusion: a systematic review. Glob spine J 6(06):592–606
Bhakta G, Ekaputra AK, Rai B, Abbah SA, Tan TC, Le BQ, Chatterjea A, Hu T, Lin T, Arafat MT, van Wijnen AJ, Goh J, Nurcombe V, Bhakoo K, Birch W, Xu L, Gibson I, Wong HK, Cool SM (2017) Fabrication of polycaprolactone-silanated β-tricalcium phosphate-heparan sulfate scaffolds for spinal fusion applications. Spine J. S1529-9430(17):31199–31203
Geurts J, Ramp D, Schären S, Netzer C (2017) Comparison of in vitro osteogenic potential of iliac crest and degenerative facet joint bone autografts for intervertebral fusion in lumbar spinal stenosis. Eur Spine J 26(5):1408–1415
Ajiboye RM, Eckardt MA, Hamamoto JT, Sharma A, Khan AZ, Wang JC (2018) Does age influence the efficacy of demineralized bone matrix enriched with concentrated bone marrow aspirate in lumbar fusions? Clin Spine Surg 31(1):E30–E35
Acknowledgements
We would like to thank our librarian Karen Sorensen M.L.S, B.A, for her contributions to this systematic review.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Morris, M.T., Tarpada, S.P. & Cho, W. Bone graft materials for posterolateral fusion made simple: a systematic review. Eur Spine J 27, 1856–1867 (2018). https://doi.org/10.1007/s00586-018-5511-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-018-5511-6